FDA Investigator Liatte Kreuger, PharmD

Liatte Kreuger, PharmD has conducted inspections on 80 sites in 8 countries as of 04 Oct 2016. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
80
Last Inspection Date:
04 Oct 2016
Investigator Role:
FDA Investigation Participant
Redica ID:
100000398
Countries of Inspections:
United States of America, Switzerland, Hungary, Canada, Israel, Germany, Finland, Romania
FDA Investigators that have inspected at least one site in common with Liatte Kreuger, PharmD:
Addam S Reynolds, Adetutu M Gidado, Alan L Truong, Alberto A Viciedo, Allen F Hall, Allen Lou, Amatul H Marium, Amy L Singer, Amy M Cramer, Ana S Cabrera, Ankur C Patel, Ann Marie Montemurro, Anna Lazar, Annemarie B Randow, Annemarie Bodnar, Anthony J Donato, Anthony M Criscuolo, Jr, Atul J Agrawal, Azza Talaat, Barbara J Maulfair, Barbara Jwilimczyk Macri, Barbara L Rellahan, PhD, Barry Rothman, Binh T Nguyen, Bo Chi, PhD, Brooke K Higgins, Byungja E Marciante, Cara M Minelli, Cary Greene, Caryn M Mcnab, CDR Ileana Barreto Pettit, Charisse K Green, Charles J Chacko, Charles L Zhou, Charles M Edwards, Charles R Cote, RIC, Cheryl A Grandinetti, Cheryl Love Harris, Christina N Maurino, Christine M Cerenzio, Christine W Twohy, Claire M Minden, Craig W Swanson, Daniel J Grabicki, Daniel J Roberts, Daniel W Cline, Daryl A Dewoskin, David H Smith, David M Beltran, Dawn L Wydner, Deborah B Nixon, Debra I Love, Delaram Moshkelani, Denise M Visco, Investigator, Dennis Cantellops Paite, Devon Jenkins, Dhaval H Patel, Diane B Radice, Dorothy J Denes, Douglas C Kovacs, Dr. Robert C Horan, MD, Dr. Zhou Chen (nmi), MD PhD, Edward P Potter, Emest F Bizjak, Emilio Z Azukwu, Emily A Walters, Emmanuel Jramos Maldonado, Eric J Cunningham, Eric L Dong, BS, Eric Rothschild, Erin D Mccaffery, Esteban Beltran, Felix Maldonado, Frank J Marciniak, Frederick F Razzaghi, Gabriel Feng, Gajendiran Mahadevan, PhD, Gale L Glinecki, Gam S Zamil, George Pyramides, Gianine E Delade, Gianine E Tompkins, Guerlain Ulysse, Gwyn G Dickinson, Haitao Li, Hamet M Toure, PharmD MPH, Helen B Ricalde, Helen Verdel, Heriberto Negron Rivera, Himanshu Gupta, PhD, Holly S Simms, Jacqueline Mdiaz Albertini, James L Dunnie, Jr, James R Birkenstamm, James W Leonette, Jananiga Vanniyasingam, Janet A Rajan, Jawaid Hamid, Jean Blackston Hill, Jean M Kelahan, Jeffrey A Sommers, Jessica S Estriplet, Joan A Loreng, Joel D Hustedt, Jogy George, Jonathan W Chapman, Jonee J Mearns, Jorge L Gonzalez, Jose A Lopez, Jose M Cayuela, Joseph F Mcginnis, RPh, Joshua P Wireman, Joy Rkozlowski Klena, Justine Tomasso, Karen A Briggs, Karen E D'orazio, Kassa Ayalew, MD, Katherine Szestypalow, Kathryn E Ogger, Keith M Reilly, Kelli F Dobilas, Kelli Regente, Kellia N Hicks, Kelly Doremus, Kenneth M Gordon, Kerry A Kurdilla, Kevin Obrien, Kim Lthomas Cruse, Kimberley A Hoefen, Kinh Q Mac, Ko U Min, Krishnaiah Yellela, Kristina L Conroy, Kristy A Zielny, Krystal O Ogunremi, L Izaam Lam, Laishan L Lam, Lata C Mathew, PhD, Lauren L Vajo, Lawrence R Johnson, Leonard H Lavi, Li Li, Libia M Lugo, Lisa Harlan, Lisa M Bellows, Lisa M Feola, Luella J Rossi, Luis A Dasta, Marcellinus D Dordunoo, Marcelo O Mangalindan, Jr, Margaret E Walsh, Margaret M Annes, Maria A Bienkowski, Maria A Reed, Maria Estrella, Maria Manzoni, PhD, Marianela Aponte Cruz, Marie B Buen Bigornia, Marjorie D Schultz, Marybet Lopez Negron, Matthew A Spataro, Matthew B Casale, Mayar M Mussa, Melba Trivera Clavell, Melissa A Freeman, Melissa B Libby, Melissa D Ray, Melissa J Garcia, Melissa T Roy, Meredith L Sheridan, Michael E Maselli, Michael R Klapal, Michael Serrano, Michele Gottshall, Miguel Gmanzano Maldonado, Mihaly S Ligmond, Mindy M Chou, Monika Borkowska, Mra M Barbosar, Mra Mcculloughj, Nadeem I Chaudhry, Namita Kothary, Nancy F Scheraga, Nancy L Rolli, Nancy M Espinal, Natasha Gupta, Nebil A Oumer, Nerizza B Guerin, Nicholas A Violand, Nicholas L Paulin, Niketa Patel, Nikki S Ramirez, Nina Yang, Niraj R Mehta, PhD, Omotunde O Osunsanmi, Parul M Patel, Patsy J Domingo, Paul L Bellamy, Paula J Bretz, Peter C Chow, Peter R Lenahan, Prabhu P Raju, Rachael A Moliver, Rachel C Harrington, Rebecca E Dombrowski, Rebecca Rodriguez, Regina T Brown, Remache, Richard D Manney, Richard J Muzeni, Robert D Tollefsen, Robert Jennings, Robin P Mathew, Rochelle K Kimmel, Rochelle L Cross, Rodney G Raiford, Rodney T Allnutt, Roger F Zabinski, Rose Ljean Mary, Russell J Glapion, Russell K Riley, Sachinkumar V Patel, Saleem A Akhtar, Sandra A Hughes, Sandra Kershaw, Sarah Adella Fave, Sarah E Mcmullen, Sarah Forney, Schultz, Scott J Lewis, Sena G Dissmeyer, Shahla Parvizi, Sharon K Thoma, PharmD, Sherri J Liu, Shirley H Isbill, Sidney B Priesmeyer, Sinai I Davis, Stephanie T Durso, Stephen J Mottola, Stephenie M Ortiz, Steven A Gonzales, Steven D Kehoe, Sue Lee Chan, Sunita Iyer, Susan M Halsted, Susan M Joseph, Susan T Hadman, Suzanne M Healy, Suzanne M Muchene, Taichun Qin, PhD, Tamil Arasu, PhD, Tania E Vizcaino, Tara G Bizjak, Tara R Gooen, Terri L Dodds, Thomas J Arista, Thomas M Herbst, Tiffani D Wilson, Tonia F Bernard, Tracey L Harris, Tressa T Lewis, Truong Xuan Nguyen (Andy), Tyanna N Hadley, Unnee Ranjan, Valerie C Reed, Valerie Reed, Victoria Spivak, Vilmary Negron Rodriguez, Virgilio F Pacio, CSO, Walden H Lee, Wayne J Meyer, Wendy G Tan, PhD, Xiaohan Cai, PhD, Yumi J Hiramine, Yvesna C Blaise, Yvins Dezan, Zakaria I Ganiyu

Liatte Kreuger, PharmD's Documents

Publish Date Document Type Title
January, 2013 EIR Eisai Inc - EIR, 2013-01-17
July, 2015 FDA 483 Millers of Wyckoff, Inc. - Form 483, 2015-07-16
January, 2012 FDA 483 Actavis Elizabeth LLC - Form 483, 2012-01-13
March, 2015 FDA 483 Response Micra Biotechnologies Inc - Form 483R, 2015-03-10
May, 2012 FDA 483 Givaudan Flavors Corporation - Form 483, 2012-05-17
October, 2016 FDA 483 PharmScript, LLC - Form 483, 2016-10-24
October, 2010 FDA 483 Sani-pure Food Laboratories Llc - Form 483, 2010-10-20
September, 2014 FDA 483 Amarin Pharma Inc. - Form 483, 2014-09-09
February, 2010 FDA 483 Scientech Laboratories, Inc. - Form 483, 2010-02-25
April, 2011 FDA 483 Actavis Elizabeth LLC - Form 483, 2011-04-26
April, 2016 FDA 483 Vetter Pharma Fertigung GmbH & Co. KG (Langenargen Eisenbahnstrasse) - Form 483, 2016-04-26
July, 2012 EIR DAVA Pharmaceuticals, Inc. - EIR, 2012-07-06
March, 2013 FDA 483 Dimensional Merchandising Inc. - Form 483, 2013-03-15
January, 2013 FDA 483 Eisai Inc - Form 483, 2013-01-17
February, 2011 FDA 483 Hoffmann La Roche Inc - Form 483, 2011-02-04
May, 2014 FDA 483 Akorn Operating Company LLC (dba Akorn) - Form 483, 2014-05-29
February, 2016 FDA 483 Response Elite Laboratories, Inc. - Form 483R, 2016-08-16
August, 2016 FDA 483 Town and Country Compounding and Consultation Services, LLC - Form 483, 2016-08-22
April, 2011 FDA 483 Response Actavis Elizabeth LLC - Form 483R, 2011-06-15
April, 2012 FDA 483 Contract Coating Inc. - Form 483, 2012-04-09
March, 2015 EIR Micra Biotechnologies Inc - EIR, 2015-03-10
April, 2011 EIR Actavis Elizabeth LLC - EIR, 2011-04-26
January, 2012 EIR Actavis Elizabeth LLC - EIR, 2012-01-13
April, 2016 FDA 483 Assia Chemical Industries Ltd. - Teva Tech Site - Form 483, 2016-04-14
February, 2016 FDA 483 Elite Laboratories, Inc. - Form 483, 2016-02-02
March, 2015 FDA 483 Micra Biotechnologies Inc - Form 483, 2015-03-10
August, 2013 EIR Vitaquest International LLC d/b/a State Nutritionals, Inc. - EIR, 2013-08-28
October, 2014 FDA 483 ACUPAC PACKAGING INC - Form 483, 2014-10-27
January, 2014 FDA 483 SGS North America Inc. - Form 483, 2014-01-21
December, 2013 FDA 483 J. Knipper and Company, Inc. - Form 483, 2013-12-17
July, 2015 FDA 483 Sun Pharmaceutical Industries, Inc. - Form 483, 2015-07-15
August, 2014 FDA 483 Konsyl Pharmaceuticals, Inc. - Form 483, 2014-08-01
May, 2013 FDA 483 Excellentia International, LLC - Form 483, 2013-05-15
June, 2010 EIR Triarco Industries, Inc. - EIR, 2010-06-02
November, 2012 FDA 483 Orion Corporation - Form 483, 2012-11-02
November, 2014 FDA 483 Brisar Industries, Inc. - Form 483, 2014-11-20
December, 2014 EIR Xellia Pharmaceuticals Ltd. - EIR, 2014-12-05
July, 2014 FDA 483 Alcami Corporation - Form 483, 2014-07-17
August, 2015 FDA 483 5N Plus Lübeck GmbH - Form 483, 2015-08-07
November, 2015 FDA 483 PETNET SOLUTIONS, INC. - Form 483, 2015-11-03
March, 2016 FDA 483 Forest Research Institute, Inc. - Form 483, 2016-03-18
July, 2012 FDA 483 DAVA Pharmaceuticals, Inc. - Form 483, 2012-07-17

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more